Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · IEX Real-Time Price · USD
2.580
-0.020 (-0.77%)
At close: Mar 28, 2024, 4:00 PM
2.610
+0.030 (1.16%)
After-hours: Mar 28, 2024, 5:46 PM EDT

Arbutus Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2008
Revenue
18.1439.0210.996.916.015.9510.71.4923.2814.95
Upgrade
Revenue Growth (YoY)
-53.51%255.11%58.92%15.02%1.11%-44.44%617.64%-93.59%55.66%-3.31%
Upgrade
Gross Profit
18.1439.0210.996.916.015.9510.71.4923.2814.95
Upgrade
Selling, General & Admin
22.4817.8317.1414.8517.731616.1339.4426.448.68
Upgrade
Research & Development
73.784.4165.549.3457.657.9362.6861.2551.5138.71
Upgrade
Other Operating Expenses
0000.0674.7621.7942.83392.4449.250.99
Upgrade
Operating Expenses
96.18102.2482.6464.25150.0995.73121.63493.13127.248.39
Upgrade
Operating Income
-78.03-63.22-71.65-57.33-144.07-89.78-110.93-491.64-103.92-33.43
Upgrade
Interest Expense / Income
0.461.732.864.012.110.230.26000
Upgrade
Other Expense / Income
-5.640.061.742.420.2-28.66-2.46-2.47-25.025.4
Upgrade
Pretax Income
-72.85-65.01-76.25-63.75-166.38-61.34-108.73-489.17-78.9-38.84
Upgrade
Income Tax
04.4400-12.66-4.28-24.32-105-16.190
Upgrade
Net Income
-72.85-69.46-76.25-63.75-153.72-57.06-84.41-384.16-62.72-38.84
Upgrade
Preferred Dividends
0012.1412.1211.1510.090.91000
Upgrade
Net Income Common
-72.85-69.46-88.39-75.87-164.87-67.15-85.32-384.16-62.72-38.84
Upgrade
Shares Outstanding (Basic)
16615110676575555534522
Upgrade
Shares Outstanding (Diluted)
16615110676575555534522
Upgrade
Shares Change
9.95%42.07%40.10%32.83%3.24%1.06%3.11%16.74%110.44%41.17%
Upgrade
EPS (Basic)
-0.44-0.46-0.83-1.00-2.89-1.21-1.56-7.24-1.38-1.80
Upgrade
EPS (Diluted)
-0.44-0.46-0.83-1.00-2.89-1.21-1.56-7.24-1.38-1.80
Upgrade
Free Cash Flow
-86.92-35.87-68.34-51.67-71.58-68.98-55.9-61.86-58.67-13.4
Upgrade
Free Cash Flow Per Share
-0.52-0.24-0.64-0.68-1.25-1.25-1.02-1.17-1.29-0.62
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-430.15%-162.03%-652.07%-829.23%-2396.84%-1510.18%-1036.73%-32973.78%-446.46%-223.59%
Upgrade
Profit Margin
-401.57%-178.01%-804.39%-1097.31%-2742.84%-1129.54%-797.42%-25765.53%-269.45%-259.73%
Upgrade
Free Cash Flow Margin
-479.16%-91.92%-621.96%-747.32%-1190.88%-1160.29%-522.44%-4148.63%-252.06%-89.59%
Upgrade
EBITDA
-70.99-61.86-71.64-57.76-162.24-58.94-106.45-488.07-78.31-38.31
Upgrade
EBITDA Margin
-391.30%-158.54%-651.96%-835.35%-2699.10%-991.34%-994.81%-32734.67%-336.46%-256.19%
Upgrade
Depreciation & Amortization
1.41.431.751.982.032.182.031.090.590.53
Upgrade
EBIT
-72.39-63.29-73.39-59.73-164.27-61.12-108.47-489.17-78.9-38.84
Upgrade
EBIT Margin
-399.04%-162.19%-667.91%-863.96%-2732.84%-1028.02%-1013.76%-32807.91%-338.99%-259.73%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).